Court Zaps Impax Suit Against Medicis Over Zit Drug

Law360, New York (April 17, 2008, 12:00 AM EDT) -- A California federal court has dismissed an Impax Laboratories Inc. case against Medicis Pharmaceutical Corp. for failing to show an immediate controversy regarding a patent for popular acne medication Solodyn.

U.S. District Judge Maxine M. Chesney of the Northern District of California granted Medicis' motion to dismiss the case on Wednesday. She found that Impax's abbreviated new drug application for a generic Solodyn and Medicis' statements that it would vigorously enforce the drug's underlying patent were not enough to keep the suit alive under the Declaratory...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.